GNH USA

Europe — EMA

Druniler

Learn about Druniler febuxostat, an oral xanthine oxidase inhibitor for gout and hyperuricemia, including uses, side effects, precautions, and drug interactions.

Febuxostat

Request sourcing

1
Pack/s

What is Febuxostat?

Druniler is a prescription medication that contains the active ingredient febuxostat, a selective non‑purine xanthine oxidase inhibitor, supplied in an oral dosage form (strength not specified). It is marketed in the European Union and belongs to the drug class of xanthine oxidase inhibitors, used to manage conditions associated with elevated uric acid levels such as gout and hyperuricemia, and may be prescribed by healthcare professionals following appropriate evaluation.

What is Febuxostat used for?

Druniler is indicated for the long‑term management of conditions characterized by excess uric acid.

- Treatment of gout in patients with hyperuricemia. - Prevention of gout flares in patients receiving urate‑lowering therapy. - Management of chronic hyperuricemia in patients with or without gout. - Adjunct therapy when diet and lifestyle modifications are insufficient to control serum uric acid.

What are the side effects of Febuxostat?

The safety profile of Druniler includes a range of observed adverse events, which are categorized by frequency.

Common: - Headache. - Nausea or vomiting. - Diarrhea. - Elevated liver enzymes.

Serious: - Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome). - Liver injury or hepatitis. - Cardiovascular events such as myocardial infarction.

What precautions apply to Febuxostat?

Before initiating Druniler, several precautionary measures should be considered to minimize risk.

- Assess renal and hepatic function prior to therapy. - Adjust dose in patients with moderate to severe renal impairment. - Monitor serum uric acid levels regularly during treatment. - Use caution in patients with a history of cardiovascular disease. - Avoid use during pregnancy and lactation unless benefits outweigh risks. - Review concomitant medications that may affect uric acid metabolism.

What does Febuxostat interact with?

Druniler may interact with other medicines; some combinations should be avoided while others require careful monitoring.

Avoid: - Strong azole antifungals (e.g., ketoconazole) that inhibit CYP enzymes. - High‑dose aspirin, which may reduce febuxostat efficacy.

Use with caution: - Warfarin, as febuxostat may increase INR. - Azathioprine or mercaptopurine, due to potential increased toxicity. - Simvastatin, because of a possible increased risk of myopathy.

Frequently asked questions

What is the mechanism of action of febuxostat in Druniler?+
Febuxostat selectively inhibits xanthine oxidase, the enzyme responsible for converting purines to uric acid, thereby reducing uric acid production in the body.
Is Druniler approved for use in the United States?+
Druniler is marketed in the European Union; regulatory approval status in other regions, including the United States, may differ and should be verified with local health authorities.
Can Druniler be taken with food?+
Febuxostat can be administered with or without food; taking it consistently with the same routine may help maintain stable absorption.
How often should serum uric acid be monitored while on Druniler?+
Serum uric acid levels are typically checked before starting therapy and periodically thereafter, often every 2–4 weeks initially, to assess treatment response.
What should a patient do if they miss a dose of Druniler?+
If a dose is missed, the patient should take it as soon as remembered unless it is close to the time of the next scheduled dose; they should not double the dose.
Is dose adjustment required for patients with kidney problems?+
Dose adjustment may be necessary for patients with moderate to severe renal impairment; clinicians should evaluate renal function before prescribing.
Does Druniler affect blood pressure or heart rate?+
Febuxostat is not primarily a cardiovascular drug, but rare serious cardiovascular events have been reported; patients with existing heart disease should be monitored.
Can Druniler be used during pregnancy or breastfeeding?+
The safety of febuxostat during pregnancy or lactation has not been established; it should only be used if the potential benefit justifies the potential risk.
What lifestyle changes complement Druniler therapy for gout?+
Patients are advised to limit purine‑rich foods, reduce alcohol intake, stay hydrated, and maintain a healthy weight to support uric acid control.
Are there any over‑the‑counter products that should be avoided with Druniler?+
High‑dose aspirin and certain herbal supplements that influence uric acid metabolism may interfere with febuxostat efficacy and should be discussed with a healthcare provider.
How long does it typically take to see a reduction in uric acid levels with Druniler?+
Uric acid reductions are often observed within a few weeks of consistent therapy, but full therapeutic effect may require several months.
What are the signs of a serious allergic reaction to Druniler?+
Symptoms such as rash, blistering, swelling of the face or throat, or difficulty breathing require immediate medical attention as they may indicate a severe hypersensitivity reaction.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Febuxostat
Route
Oral Use
Manufacturer
Sandoz Pharmaceuticals D.D.
Origin
EU

Related products